Your Research Partner in Finding
and Expressing Therapeutic Compounds
 

 

 

Product Datasheet

 

Product Name

Gallidermin

 

Product number

SgG-95-01

 

Product type 

Peptide, Lantibiotic

 

Source

Staphylococcus gallinarum Tü3298

 

Description

Chromatographically or HPLC purified peptide of high purity and activity from a wild type S. gallinarum strain. Peptide size is 2164 Da.

 

Solubility

Gallidermin is soluble e.g. in water, ethanol, methanol (1 mg/ml)

 

Relevance

It is a natural antimicrobial peptide, which belongs to the class of 'lantibiotics' and is active against many Gram-positive pathogens.

It is active towards both growing as well as non-dividing bacteria.

No cross resistance to Methicillin, Tetracycline, Vancomycin, Erythromycin, Clindamycin, or other lantibiotics such as Nisin.

Mode of action:

- Interference with the biosynthesis of the bacterial cell wall.

- Formation of non-specific transmembrane pores in an energy-dependent fashion

Intended applications:

·          Treatment of multidrug resistant strains of Staphylococcus aureus

·          cosmetic preservation

·          protective against Propionibacterium acnes, involved in certain forms of acne disease

 

Storage buffer 

-

 

Form

white Powder (Lyophilized)

 

Storage instructions

Store dry at 4°C

 

Purification notes 

Chromatographically purified. Appears as a single peak in HPLC analysis.

 

Safety Notes 

For research use only! Not intended for diagnostic or therapeutic use! Do not breathe dust!

 

 References

Kellner, R., Jung, G., Hörner, T., Zähner, H., Schnell, N., Entian, K.-D., and Götz, F. (1988). Gallidermin: a new lanthionine containing polypeptide antibiotic. Eur. J. Biochem. 177: 53-59.

Kempf, M., Theobald, U. and Fiedler, H.-P. (1999) Economic improvement of the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol. Letters 21: 663-667.

Kupke, T., and Götz, F. (1996). Post-translational modification of lantibiotics. Antonie van Leeuwenhoek 69: 139-150.

 
     

 

   
© 2004 DR PETRY genmedics GMBH